VirtualScopics Schedules Third Quarter 2008 Earnings An... ( ROCHESTER N.Y. Oct. 28 /- Virtual...)

VirtualScopics Schedules Third Quarter 2008 Earnings Announcement

Date:10/28/2008

ROCHESTER, N.Y., Oct. 28 /PRNewswire-FirstCall/ -- VirtualScopics, Inc. (Nasdaq: VSCP), a leading provider of quantitative imaging for clinical trials, today announced that on November 4, 2008 it will release its 2008 third quarter financial results for the period ended September 30, 2008. The company will host a conference call to discuss these results on Wednesday, November 5, 2008 at 11:00 a.m. EST.

VirtualScopics' President and Chief Executive Officer, Jeff Markin, and Chief Business and Financial Officer, Molly Henderson, will provide a business update and discuss the company's results for the third quarter 2008, during the conference call.

Interested participants should call 877-407-0778 when calling within the United States or 201-689-8565 when calling internationally. There will be a playback available until December 5, 2008. To listen to the playback, please call 877-660-6853 when calling within the United States or 201-612-7415 when calling internationally. For the replay, please use account number: 286, conference ID number: 301146.

This call is being Web cast by Vcall and can be accessed at http://www.virtualscopics.com . The Web cast will be available for 30 days after the call.

About VirtualScopics, Inc.

VirtualScopics, Inc. is a leading provider of imaging solutions to accelerate drug and medical device development. VirtualScopics has developed a robust software platform for analysis and modeling of both structural and functional medical images. In combination with VirtualScopics' industry-leading experience and expertise in advanced imaging biomarker measurement, this platform provides a uniquely clear window into the biological ac
'/>"/>

SOURCE VirtualScopics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine news :

1. VirtualScopics Reports Second Quarter 2008 Results
2. VirtualScopics Receives NASDAQ Delisting Notice; Company Files Appeal to Stay Delisting
3. VirtualScopics Backlog Exceeds a Record $20 Million
4. VirtualScopics Announces $4.35 Million Private Placement
5. Varian Medical Systems Schedules Fiscal Year End Review in New York
6. Optical Cable Corporation Schedules Conference Call to Discuss Third Quarter 2008 Results
7. Birner Dental Management Services, Inc. Schedules Earnings Call to Discuss Second Quarter 2008 Results
8. The Ensign Group Schedules 2008 Second Quarter Earnings Call for Thursday, August 7, 2008
9. Thoratec Schedules Second Quarter 2008 Conference Call, Webcast
10. AMICAS Schedules Second Quarter Earnings Call
11. Mylan Schedules Financial Results Conference Call and Live Webcast for the Second Quarter Fiscal 2008

Post Your Comments:

(Date:11/9/2009)...y 5 percent of seniors have changed Medicare plans... service and improved coverage among biggest drive...nears , , Belleville, Il ...f seniors have changed their Medicare plan since b... report they are likely to or are considering swit...

(Date:11/9/2009)...wswire/ -- HUYA Bioscience International, a lead...tion, today announced a strategic partnership with...sity of China. The agreement is another in a serie... China,s leading research and development institut...nt and commercialization of novel biopharmaceutica...

(Date:11/9/2009)...young athletes are under increasing pressure to pl... University Health System study of 519 junior tenn...eases the risk of injury. Researchers who analyzed... junior competition found that players who special...rom tournaments for medical reasons, typically inj...

(Date:11/9/2009)...dy involving 2,453 women ages 18 to 68 found that ... a partner contributed to higher ratings of pleasu... have long been recommended to women to improve th...risk of vaginal tearing, yet strikingly little ava...nts or associated vaginal symptoms. , The study...

(Date:11/8/2009)...ewswire-USNewswire/ -- Jon O,Brien, president of C...t about the passage of HR 3962: ,, "Behavior i...lot about core values. We in the prochoice communi...come the struggles ordinary Americans have making ...fford basic healthcare or have to choose between m...

Breaking Medicine News(10 mins):Health News:Few Change Medicare Plans Each Year, But Three Times as Many Are Considering a Change in 2010, Allsup Survey Finds, 2 Health News:Few Change Medicare Plans Each Year, But Three Times as Many Are Considering a Change in 2010, Allsup Survey Finds, 3 Health News:Few Change Medicare Plans Each Year, But Three Times as Many Are Considering a Change in 2010, Allsup Survey Finds, 4 Health News:Few Change Medicare Plans Each Year, But Three Times as Many Are Considering a Change in 2010, Allsup Survey Finds, 5 Health News:HUYA Bioscience International Establishes Strategic Partnership with School of Medicine and Pharmacy, Ocean University of China 2 Health News:Young tennis players who play only 1 sport are more prone to injuries 2 Health News:Indiana U. at APHA: Studies about why men and women use lubricants during sex 2 Health News:Indiana U. at APHA: Studies about why men and women use lubricants during sex 3 Health News:Catholics for Choice Statement on Healthcare Reform Bill 2

[0] Few Change Medicare Plans Each Year, But Three Times as Many Are Considering a Change in 2010, Allsup Survey Finds,[0] HUYA Bioscience International Establishes Strategic Partnership with School of Medicine and Pharmacy, Ocean University of China [0] Young tennis players who play only 1 sport are more prone to injuries [0] Indiana U. at APHA: Studies about why men and women use lubricants during sex [1] Catholics for Choice Statement on Healthcare Reform Bill

...GTON, Sept. 23 Homeless veterans in 35,states, th...re assistance,thanks to Department of Veterans Aff...ity groups to create 1,526 beds for homeless veter... B. Peake.,"Our partnerships with community-based ...

...ome Foreclosures Displacing People and Dogs Alike,...eed Adopters, DENVER, Sept. 23 The housing crisi... unexpected group: dogs., Driven largely by the r... across the country say they are receiving dogs,ev...

...found giving it before radiation raised death risk...HealthDay News) -- Older men with early-stage pros...adiation seed implant therapy face a 20 percent gr... risks of death from any cause linked to androgen-...

... Program targets individuals u..., Irvine, Calif. (Vocus) S... to provide care to the most underserved populatio...diabetes management services to members of the Hea...

... Scribe announces a version of...ion and document archival technology for free , ...tember 23, 2008 -- Scribe Healthcare Technologies,... management, is now offering a version of its plat...

...ANA, Calif., Sept. 22 Grubb & Ellis,Healthcare RE...ma City,Medical Portfolio, comprising two medical ... and 5701 N. Portland, the buildings are situated ...ctive additions to the Grubb,& Ellis Healthcare RE...

VA Announces $36 Million in Grants for Homeless Programs This October, Bring Home a Shelter Dog for American Humane's Adopt-A-Dog Month(R)Hormone Therapy Not Best for Older Prostate Cancer Patients LifeMasters Announces Agreement to Offer Disease Management Services to High-Risk Wisconsin Residents Medical Dictation and Transcription Platform is Offered for Free Grubb & Ellis Healthcare REIT Acquires Oklahoma City Medical Portfolio

(Date:11/6/2009).... 6 Philips Respironics applauds t...Prevention (CDC) to raise awareness about an impor...iency. The CDC,s release of the first-ever governm... sleeplessness is a milestone in quantifying the s...e educator, industry leader and sleep therapy manu...

(Date:11/6/2009)...wswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CY...financial results for the second quarter ended Oct...2010 on Wednesday, November 18, 2009 at 5:00 PM ES...discuss those results on Thursday, November 19, 20... Quarter Results Conference Call Instructions ,...

(Date:11/6/2009)... , - Trial Will Compare N...eatment of Multi-Resistant Staphylococcus Aureus (...pharmaceutical company focused on the discovery an...rcome the significant global,problem of microbial ... oral,antibacterial NXL103 (flopristin/linopristin...

Breaking Medicine Technology:Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2 Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 Second Quarter Financial Results 2 Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2 Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3 Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4 Florida Celebrates National Healthcare Quality Week 59698 1 Florida Celebrates National Healthcare Quality Week 59698 2 ULORIC 28R 29 28febuxostat 29 Demonstrated Efficacy for Management of Hyperuricemia in Patients with Gout 5547 1 ULORIC 28R 29 28febuxostat 29 Demonstrated Efficacy for Management of Hyperuricemia in Patients with Gout 5547 2 ULORIC 28R 29 28febuxostat 29 Demonstrated Efficacy for Management of Hyperuricemia in Patients with Gout 5547 3 ULORIC 28R 29 28febuxostat 29 Demonstrated Efficacy for Management of Hyperuricemia in Patients with Gout 5547 4 ULORIC 28R 29 28febuxostat 29 Demonstrated Efficacy for Management of Hyperuricemia in Patients with Gout 5547 5 Video Games Can Play Havoc With Kids Joints 59696 1 Video Games Can Play Havoc With Kids Joints 59696 2 Video Games Can Play Havoc With Kids Joints 59696 3

[0] Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation [0] Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 Second Quarter Financial Results [0] Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

...ated Foot & Ankle Specialists,today announced it i...etes,to participate in the MATRIX clinical trial. ... Excellarate, for the potential treatment of,patie...rate is an,investigational product designed to sti...trial is a randomized, double-blind safety and eff...

...Feb. 25 Joseph F. Finn, Jr.,CPA, the Assignee for...sult,of growing interest from prospective buyers, ... advancement of the company,s proprietary,benzoxaz...ates in,combination antibiotic therapy. Rifalazil ...ost of the interest for combination antibiotics ha...

Other Medicine Technology:ActivBiotics Proposes Development Strategy for Its Novel Rifamycin Antibiotics 2

Associated Foot & Ankle Specialists Enrolling Patients With Chronic Diabetic Foot Ulcers for MATRIX Clinical Trial ActivBiotics Proposes Development Strategy for Its Novel Rifamycin Antibiotics

Ballard Neonatal and Pediatric Trach Care Elbow

Ballard Neonatal and Pediatric Trach Care Manifold

Portex® Blue Line ULTRA® Tracheostomy Tubes

...e Line ULTRA® Suctionaid® tracheostomy tub... removal of secretions from above the tracheostomy...uctionaid® tracheostomy tubes provide an addit...ons from above the tracheostomy tube cuff helping ...

Medicine Products:

Ballard Neonatal and Pediatric Trach Care Elbow Ballard Neonatal and Pediatric Trach Care Manifold Portex® Blue Line ULTRA® Tracheostomy Tubes Portex® Blue Line ULTRA® Suctionaid® Tracheostomy Tubes

VirtualScopics Schedules Third Quarter 2008 Earnings An...( ROCHESTER N.Y. Oct. 28 /- Virtual...),Health